Investor
Accele Venture Partners
The investment arm of Oklahoma City life sciences accelerator Accele Biopharma. It co-led the 2014 Series A for Otologic Pharmaceutics with i2E and later made a follow-on investment in Synereca Pharmaceuticals.
Category: Tulsa and Oklahoma ecosystem
For example: A life sciences founder studies Otologic Pharmaceutics’ financing to see how a specialist fund and an Oklahoma investor shared the lead.
Official site: otologicpharma.com
Connects to 3
- Otologic Pharmaceutics Organization
- i2E Organization, nonprofit
- Series A Concept
This glossary is plain-language orientation, not legal or financial advice. Before you decide on a company structure, a contract, taxes or a fundraising deal, talk with a lawyer or an accountant.